Detalhe da pesquisa
1.
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Cancer Treat Rev
; 110: 102464, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194908